Dr. Lai Kar Neng - Nephrology
Specialist in Nephrology
Highlights
- MCHK RegisteredVerified
- BilingualCantonese · English
- 1 LocationsJardine's Lookout
- Specialist in NephrologyBachelor of Medicine and Bachelor of Surgery (MBBS) · Doctor of Medicine (MD) · Fellow of the Royal College of Physicians of Edinburgh · Medical degree 1975
- InsuranceBeing compiled｜See details
About
Dr. Lai Kar Neng practises Nephrology in Jardine's Lookout, Hong Kong. They speaks Cantonese, English.
Education
Specialist in Nephrology
- Bachelor of Medicine and Bachelor of Surgery (MBBS)Bachelor of Medicine and Bachelor of Surgery (MBBS)1975
- Doctor of Medicine (MD)Doctor of Medicine (MD)1983
- Fellow of the Royal College of Physicians of EdinburghFellow of the Royal College of Physicians of Edinburgh1988
- Fellow of the Royal College of Physicians (London)Fellow of the Royal College of Physicians (London)1991
Hong Kong Academy of Medicine fellowships
- FHKCPFellow, Hong Kong College of Physicians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Locations
Hong Kong Sanatorium & Hospital
2 Village Road, Happy Valley, Hong Kong
Get Directions →Jardine's Lookout
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Lai Kar Neng? Claim page and update insurance →
FAQ
Is Dr. Lai Kar Neng any good?
Dr. Lai Kar Neng practises Nephrology in Jardine's Lookout, Hong Kong. They speaks Cantonese, English. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Lai Kar Neng do?
Dr. Lai Kar Neng practises in Nephrology.
Where does Dr. Lai Kar Neng practise?
Dr. Lai Kar Neng practises at Hong Kong Sanatorium & Hospital, Jardine's Lookout.
What languages does Dr. Lai Kar Neng speak?
Dr. Lai Kar Neng speaks Cantonese, English.
Are you Dr. Lai Kar Neng? Claim this page to update and manage.
ClaimResearch and publications
31 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- C5a/C5aR1 mediates AKI-CKD transition by enhancing autophagy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
- Add-on astragalus in type 2 diabetes and chronic kidney disease: A multi-center, assessor-blind, randomized controlled trial.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024
- Long Non-coding RNA NEAT1 , NOD-Like Receptor Family Protein 3 Inflammasome, and Acute Kidney Injury.Journal of the American Society of Nephrology : JASN · 2024
- The long noncoding RNA Meg3 mediates TLR4-induced inflammation in experimental obstructive nephropathy.Clinical science (London, England : 1979) · 2023
- Add-on Rehmannia-6-Based Chinese Medicine in Type 2 Diabetes and CKD: A Multicenter Randomized Controlled Trial.Clinical journal of the American Society of Nephrology : CJASN · 2023
- Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
- Long-term outcomes of add-on direct renin inhibition in igA nephropathy: a propensity score-matched cohort study.Journal of nephrology · 2023
- Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signaling.Clinical science (London, England : 1979) · 2021
- Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy.Frontiers in physiology · 2021
- Global REnal Involvement of CORonavirus Disease 2019 (RECORD): A Systematic Review and Meta-Analysis of Incidence, Risk Factors, and Clinical Outcomes.Frontiers in medicine · 2021
- Direct Renin Inhibition in Non-diabetic chronic Kidney disease (DRINK): a prospective randomized trial.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
- The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis.Clinical science (London, England : 1979) · 2020
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
Elsewhere on the web
Hospital pages
These links are matched automatically by the doctor's name and are not confirmed by the doctor. Names repeat in Hong Kong — open a link to check.
For reference only. Not medical advice. Read full disclaimer